Clinical Trial Update: Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients

View source ↗

Summary

Completed trial evaluating rasburicase for chemotherapy- or malignancy-induced hyperuricemia in leukemia and lymphoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia
• Leukemia
• Lymphoma
• Tumor Lysis Syndrome

Drugs mentioned

• Rasburicase (rasburicase)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Leukemia, Lymphoma | Status: COMPLETED